• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

开具具有药物基因组学可操作性阿片类药物的基层医疗患者的用药暴露模式

Medication Exposure Patterns in Primary Care Patients Prescribed Pharmacogenetically Actionable Opioids.

作者信息

Knisely Mitchell R, Carpenter Janet S, Broome Marion E, Holmes Ann M, Von Ah Diane, Skaar Todd, Draucker Claire Burke

机构信息

Duke University, Durham, North Carolina, USA.

Indiana University, Indianapolis, Indiana, USA.

出版信息

Qual Rep. 2018 Aug;23(8):1861-1875. Epub 2018 Aug 7.

PMID:31355374
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6660172/
Abstract

Current approaches to assessing medication exposure fail to capture the complexity of the phenomenon and the context in which it occurs. This study's purpose was to develop a typology of subgroups of patients who share common patterns of medication exposure. To create the typology, we used an exemplar sample of 30 patients in a large public healthcare system who had been prescribed the pharmacogenetically actionable opioids codeine or tramadol. Data related to medication exposure were drawn from large data repositories. Using a person-oriented qualitative approach, eight subgroups of patients who shared common patterns of medication exposure were identified. The subgroups had one of five opioid prescription patterns (i.e., singular, episodic, switching, sustained, multiplex), and one of three types of primary foci of medical care (i.e., pain, comorbidities, both). The findings reveal medication exposure patterns that are dynamic, multidimensional, and complex, and the typology offers an innovative approach to assessing medication exposure.

摘要

当前评估药物暴露的方法未能捕捉到该现象的复杂性及其发生的背景。本研究的目的是建立具有共同药物暴露模式的患者亚组类型学。为了创建该类型学,我们在一个大型公共医疗系统中选取了30名患者作为示例样本,这些患者被开具了具有药物遗传学可操作的阿片类药物可待因或曲马多。与药物暴露相关的数据来自大型数据库。采用以人为本的定性方法,确定了具有共同药物暴露模式的八个患者亚组。这些亚组具有五种阿片类药物处方模式之一(即单一、 episodic、转换、持续、多重),以及三种主要医疗关注点之一(即疼痛、合并症、两者皆有)。研究结果揭示了动态、多维且复杂的药物暴露模式,该类型学为评估药物暴露提供了一种创新方法。

相似文献

1
Medication Exposure Patterns in Primary Care Patients Prescribed Pharmacogenetically Actionable Opioids.开具具有药物基因组学可操作性阿片类药物的基层医疗患者的用药暴露模式
Qual Rep. 2018 Aug;23(8):1861-1875. Epub 2018 Aug 7.
2
Characteristics of Prescription Opioid Analgesics in Pregnancy and Risk of Neonatal Opioid Withdrawal Syndrome in Newborns.妊娠期间处方类阿片类镇痛药的特点与新生儿阿片类戒断综合征的风险。
JAMA Netw Open. 2022 Aug 1;5(8):e2228588. doi: 10.1001/jamanetworkopen.2022.28588.
3
Analysis of pediatric opioid analgesics prescribed in a large pediatric hospital over a 5-year period.5 年期间大型儿科医院开具的小儿阿片类镇痛药分析。
J Opioid Manag. 2022 Jul-Aug;18(4):327-334. doi: 10.5055/jom.2022.0728.
4
Prescription opioid utilization patterns, and associated outcomes, among privately insured patients prescribed opioids to manage pain associated with osteoarthritis.在因骨关节炎疼痛而开具处方的私人保险患者中,处方类阿片药物的使用模式及相关结局。
Curr Med Res Opin. 2023 Aug;39(8):1147-1156. doi: 10.1080/03007995.2023.2234727. Epub 2023 Jul 20.
5
Prescribing of pain medication in palliative care. A survey in general practice.姑息治疗中止痛药物的处方。一项全科医疗调查。
Pharmacoepidemiol Drug Saf. 2009 Jan;18(1):16-23. doi: 10.1002/pds.1678.
6
Impact of CYP2D6 Pharmacogenomic Status on Pain Control Among Opioid-Treated Oncology Patients.CYP2D6 药物基因组学状态对接受阿片类药物治疗的肿瘤患者疼痛控制的影响。
Oncologist. 2021 Nov;26(11):e2042-e2052. doi: 10.1002/onco.13953. Epub 2021 Sep 19.
7
Patterns in opioid prescription in the United States by region and prescribers over a 4-year period.美国四年期间按地区和开处方者划分的阿片类药物处方模式。
J Opioid Manag. 2019 Nov/Dec;15(6):499-506. doi: 10.5055/jom.2019.0541.
8
Prescribed opioid analgesic use developments in three Nordic countries, 2006-2017.2006 - 2017年三个北欧国家的处方阿片类镇痛药使用情况发展
Scand J Pain. 2019 Apr 24;19(2):345-353. doi: 10.1515/sjpain-2018-0307.
9
The Role of Pharmacogenomics in Opioid Prescribing.药物基因组学在阿片类药物处方中的作用。
Curr Treat Options Oncol. 2022 Oct;23(10):1353-1369. doi: 10.1007/s11864-022-01010-x. Epub 2022 Aug 24.
10
Changes in Australian prescription opioid use following codeine rescheduling: A retrospective study using pharmaceutical benefits data.澳大利亚处方类阿片使用变化:基于药品福利数据的回顾性研究
Int J Drug Policy. 2019 Dec;74:170-173. doi: 10.1016/j.drugpo.2019.08.008. Epub 2019 Oct 14.

本文引用的文献

1
Pharmacogenomically actionable medications in a safety net health care system.安全网医疗保健系统中具有药物基因组学可操作性的药物。
SAGE Open Med. 2016 Jan 7;4:2050312115624333. doi: 10.1177/2050312115624333. eCollection 2016.
2
A systematic review of medication exposure assessment in prospective cohort studies of community dwelling older australians.对澳大利亚社区居住老年人前瞻性队列研究中药物暴露评估的系统评价。
PLoS One. 2015 Apr 24;10(4):e0124247. doi: 10.1371/journal.pone.0124247. eCollection 2015.
3
Pharmacogenetics of opioid response.阿片类药物反应的遗传药理学。
Clin Pharmacol Ther. 2015 Feb;97(2):125-7. doi: 10.1002/cpt.23. Epub 2014 Dec 9.
4
Polypharmacy and chronic pain: harm exposure is not all about the opioids.多重用药与慢性疼痛:药物伤害并非都与阿片类药物有关。
Pain Med. 2015 Mar;16(3):472-9. doi: 10.1111/pme.12586. Epub 2014 Oct 3.
5
Genotype-guided drug prescribing: a systematic review and meta-analysis of randomized control trials.基因型指导下的药物处方:随机对照试验的系统评价和荟萃分析
Br J Clin Pharmacol. 2015 Oct;80(4):868-77. doi: 10.1111/bcp.12475. Epub 2015 Jul 22.
6
Opioid prescribing by multiple providers in Medicare: retrospective observational study of insurance claims.医疗保险中多名提供者开具阿片类药物处方的情况:保险索赔的回顾性观察性研究。
BMJ. 2014 Feb 19;348:g1393. doi: 10.1136/bmj.g1393.
7
Clinical Pharmacogenetics Implementation Consortium guidelines for cytochrome P450 2D6 genotype and codeine therapy: 2014 update.临床药物遗传学实施联盟 CYP2D6 基因型和可待因治疗指南:2014 年更新。
Clin Pharmacol Ther. 2014 Apr;95(4):376-82. doi: 10.1038/clpt.2013.254. Epub 2014 Jan 23.
8
Promises and challenges of pharmacogenetics: an overview of study design, methodological and statistical issues.药物遗传学的前景与挑战:研究设计、方法学及统计学问题综述
JRSM Cardiovasc Dis. 2012 Apr 5;1(1):cvd.2012.012001. doi: 10.1258/cvd.2012.012001.
9
Opioid therapy pharmacogenomics for noncancer pain: efficacy, adverse events, and costs.非癌性疼痛的阿片类药物治疗药物基因组学:疗效、不良事件及成本
Pain Res Treat. 2013;2013:943014. doi: 10.1155/2013/943014. Epub 2013 Sep 18.
10
Measure once, cut twice--adding patient-reported outcome measures to the electronic health record for comparative effectiveness research.一次测量,两次裁剪——为比较疗效研究在电子健康记录中添加患者报告的结果测量。
J Clin Epidemiol. 2013 Aug;66(8 Suppl):S12-20. doi: 10.1016/j.jclinepi.2013.04.005.